Page 3 - Brightgene Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

), Application (Ebola, SARS-COV, MERS-COV, COVID-19
), End User (Hospitals, Clinics, Pharmacy and Drug Stores, Online Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Remdesivir market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 9,925.61 million by 2028 and will grow at a CAGR of 27.46% in the above mentioned forecast period. ....

United States , Hong Kong , United Kingdom , South Africa , Saudi Arabia , South Korea , Zydus Cadila , Brightgene Bio , Cipla Inc , Drug Stores , Beximco Pharmaceuticals Ltd , Technology Penetration , Gilead Sciences Inc , Jubilant Life Sciences , Everest Organics , Market Research , Pfizer Inc , Technology Co Ltd , Reddy Laboratories Ltd , Hikma Pharmaceuticals , Hunan Warrant Chiral Pharmaceutical Co Ltd , Ferozsons Laboratories , Global Remdesivir Market , Patient Type , Lyophilized Powder , Concentrated Solution ,